glp 1 action Glucagon-like peptide-1 Glucagon, GLP-1 and Thermogenesis

Just a simpler approach to weight loss

Stopping GLP-1 therapy triggers predictable metabolic shifts within weeks

Learn why some patients cannot tolerate these medications and when endoscopic sleeve may be considered.

This study demonstrated that the long-acting GLP-1R agonist, NLY01, has different health benefits in two different mouse models of MS

Simple, gentle at-home sample collection with CLIA lab processing and clear online results-designed for convenient check-ins from start to finish Comprehensive Biomarker Panel: Tracks four key wellness areas including liver function, lipid health with LDL, HDL, total cholesterol and triglycerides, kidney filtration with eGFR, Creatinine and BUN, plus pancreatic enzyme activity monitoring

Understanding response variabilityinformed by biomarkers and genetic contextcan help guide conversations with healthcare providers about optimization strategies